B7-H2 Is a Costimulatory Ligand for CD28 in Human

被引:117
|
作者
Yao, Sheng [1 ]
Zhu, Yuwen [1 ]
Zhu, Gefeng [1 ]
Augustine, Mathew [2 ]
Zheng, Linghua [1 ]
Goode, Diana J. [2 ]
Broadwater, Megan [2 ]
Ruff, William [2 ]
Flies, Sarah [2 ]
Xu, Haiying [2 ]
Flies, Dallas [1 ]
Luo, Liqun [1 ]
Wang, Shengdian [3 ]
Chen, Lieping [1 ]
机构
[1] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA
[3] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100101, Peoples R China
基金
美国国家卫生研究院;
关键词
PHOSPHATIDYLINOSITOL; 3-KINASE; STRUCTURAL BASIS; ICOS DEFICIENCY; CO-STIMULATION; T-CELLS; CTLA-4; ACTIVATION; EXPRESSION; RECEPTOR; BINDING;
D O I
10.1016/j.immuni.2011.03.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 and CTLA-4 are cell surface cosignaling molecules essential for the control of T cell activation upon the engagement of their ligands B7-1 and B7-2 from antigen-presenting cells. By employing a receptor array assay, we have demonstrated that B7-H2, best known as the ligand of inducible costimulator, was a ligand for CD28 and CTLA-4 in human, whereas these interactions were not conserved in mouse. B7-H2 and B7-1 or B7-2 interacted with CD28 through distinctive domains. B7-H2-CD28 interaction was essential for the costimulation of human T cells' primary responses to allogeneic antigens and memory recall responses. Similar to B7-1 and B7-2, B7-H2 costimulation via CD28 induced survival factor Bcl-xL, downregulated cell cycle inhibitor p27(kip1), and triggered signaling cascade of ERK and AKT kinase-dependent pathways. Our findings warrant re-evaluation of CD28 and CTLA-4's functions previously attributed exclusively to B7-1 and B7-2 and have important implications in therapeutic interventions against human diseases.
引用
收藏
页码:729 / 740
页数:12
相关论文
共 50 条
  • [41] Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cells
    Medina, Miguel A.
    Couturier, Jacob
    Feske, Marsha L.
    Mahne, Ashley E.
    Turner, Mary
    Yu, Xiaoyong
    Kozinetz, Claudia A.
    Orozco, Aaron F.
    Hutchison, Alexander T.
    Savidge, Tor C.
    Rodgers, John R.
    Lewis, Dorothy E.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (05) : 759 - 771
  • [42] Cutting Edge: A Role for Inside-Out Signaling in TCR Regulation of CD28 Ligand Binding
    Sanchez-Lockhart, Mariano
    Kim, Minsoo
    Miller, Jim
    JOURNAL OF IMMUNOLOGY, 2011, 187 (11) : 5515 - 5519
  • [43] Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
    Schildberg, Frank A.
    Klein, Sarah R.
    Freeman, Gordon J.
    Sharpe, Arlene H.
    IMMUNITY, 2016, 44 (05) : 955 - 972
  • [44] Molecular cloning and sequencing of canine T-cell costimulatory molecule (CD28)
    Khatlani, TS
    Ma, ZY
    Okuda, M
    Onishi, T
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2001, 78 (3-4) : 341 - 348
  • [45] CD8+CD122+PD-1+Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
    Liu, Huazhen
    Qiu, Feifei
    Wang, Yuanzhong
    Zeng, Qiaohuang
    Liu, Cuihua
    Chen, Yuchao
    Liang, Chun-Ling
    Zhang, Qunfang
    Han, Ling
    Dai, Zhenhua
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [46] B7/CD28 in central tolerance: costimulation promotes maturation of regulatory T cell precursors and prevents their clonal deletion
    Hinterberger, Maria
    Wimsbergert, Gerald
    Klein, Ludger
    FRONTIERS IN IMMUNOLOGY, 2011, 2
  • [47] Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy
    Agrewala, JN
    Kumar, B
    Vohra, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (01) : 56 - 63
  • [48] The CD28/B7 Pathway: A Novel Regulator of Plasma Cell Function
    Njau, Modesta N.
    Jacob, Joshy
    CROSSROADS BETWEEN INNATE AND ADAPTIVE IMMUNITY IV, 2013, 785 : 67 - 75
  • [49] A CD2/CD28 chimeric receptor triggers the CD28 signaling pathway in CTLL.2 cells
    AL Feldhaus
    L Evans
    RA Sutherland
    LA Jones
    Gene Therapy, 1997, 4 : 833 - 838
  • [50] Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway
    Fenwick, Craig
    Loredo-Varela, Juan-Luis
    Joo, Victor
    Pellaton, Celine
    Farina, Alex
    Rajah, Navina
    Esteves-Leuenberger, Line
    Decaillon, Thibaut
    Suffiotti, Madeleine
    Noto, Alessandra
    Ohmiti, Khalid
    Gottardo, Raphael
    Weissenhorn, Winfried
    Pantaleo, Giuseppe
    JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (07) : 1525 - 1541